Cancer advocate Jenny R. Mosier recently participated in the evaluation of research applications submitted to the Peer Reviewed Cancer Research Program (PRCRP) sponsored by the Department of Defense. Ms. Mosier, Executive Director of Michael Mosier Defeat DIPG™ Foundation, was nominated for participation in the program by the National Brain Tumor Society. As a consumer reviewer, she was a full voting member, along with prominent scientists, at meetings to help determine how the $50 million appropriated by Congress for Fiscal Year 2016 (FY16) will be spent on future research on eleven specific cancers: bladder, colorectal, kidney, liver, stomach, and pancreatic cancer; lymphoma; melanoma and other skin cancers; mesothelioma, neuroblastoma, pediatric brain tumors; and Listeria vaccine for cancer and immunotherapy research.
Consumer reviewers are asked to represent the collective view of individuals living with these cancers, family members, and those who may be affected in the future when they prepare comments on the impact and/or military relevance of the research on issues such as prevention, screening, diagnosis, treatment, and quality of life after diagnosis.
Commenting on serving as a consumer reviewer, Ms. Mosier said that “Participation as a peer reviewer for the Peer Reviewed Cancer Research Program offers the unique and meaningful opportunity to ensure the voices of those who suffer from the disease are heard. By interacting directly with the scientific reviewers considering grant applications, we can ensure that patient concerns inform evaluation of these important research grant applications. I am grateful to the National Brain Tumor Society for nominating me for this position and to my fellow panel members for the robust and productive discussion.”
Consumer advocates and scientists have worked together in this unique partnership to evaluate the scientific merit of research applications proposed for these specific cancers since 2009. To date, more than 120 consumer reviewers have served on panels alongside scientists in the review process for the program. Colonel Wanda L. Salzer, M.D., Director of the Congressionally Directed Medical Research Programs, expressed her appreciation for the perspectives of the consumer advocates in the scientific review sessions: “The Consumer Reviewers on each panel are instrumental in helping the scientists understand the patient’s perspective and provide valuable insight into the potential impact of the proposed project. They bring with them a sense of urgency and remind all of the human element involved in medical research.”
Scientists applying propose to conduct innovative cancer research aimed at improving the lives of all individuals living with these cancers and their families. The PRCRP fills important gaps not addressed by other funding agencies by supporting groundbreaking, high-risk, high-gain research while encouraging out-of-the-box thinking.
More information about the Department of Defense Peer Reviewed Cancer Research Program is available at the Website: http://cdmrp.army.mil.
For a printer-friendly copy of this release, please CLICK HERE.
Gail Whitehead, Public Affairs, 301-619-7783
Executive Director, Michael Mosier Defeat DIPG Foundation, 240-903-0827